Kusniec J, Strasberg B, Sclarovsky S, Klainman E, Agmon J
Israel and Ione Massada Center for Heart Diseases, Beilinson Medical Center, Petah Tikva, Israel.
Chest. 1988 Sep;94(3):584-8. doi: 10.1378/chest.94.3.584.
The effect of intravenous (IV) amiodarone (300 mg) on heart rate was investigated in 22 patients with acute myocardial infarction (18) or ischemia (4) and sinus tachycardia. There were 11 men and 11 women (age range, 48 to 83 years; mean, 63.5). Amiodarone IV slowed the mean heart rate from 109 +/- 14 beats/min to 94 +/- 15 beats/min (p less than 0.0005). There was a linear correlation between the initial heart rate (preamiodarone) and the final heart rate (postamiodarone), (r = 0.6930, p less than 0.0005). Most of the patients with initial heart rates higher than the mean maintained relatively high heart rates (above the mean), while most patients with lower initial heart rates showed low heart rates (below the mean) after amiodarone administration. Patients in Killip class 1 showed a significant reduction in heart rate after receiving amiodarone, from a mean of 105 +/- 10 to 88 +/- 11 beats/min (p less than 0.01). Patients in Killip class 2 also had reduced heart rates (118 +/- 14 to 81 +/- 39 beats/min), but these changes were not statistically significant. Of the three patients in Killip class 3 to 4, the heart rate slowed by 10 beats/min in one, while in the remaining two no changes were observed. There were no significant side effects from the administration of amiodarone.
在22例急性心肌梗死(18例)或心肌缺血(4例)并伴有窦性心动过速的患者中,研究了静脉注射胺碘酮(300毫克)对心率的影响。患者共11名男性和11名女性(年龄范围48至83岁;平均63.5岁)。静脉注射胺碘酮后,平均心率从109±14次/分钟降至94±15次/分钟(p<0.0005)。初始心率(胺碘酮用药前)与最终心率(胺碘酮用药后)之间存在线性相关性(r = 0.6930,p<0.0005)。大多数初始心率高于平均值的患者在用药后维持相对较高的心率(高于平均值),而大多数初始心率较低的患者在使用胺碘酮后心率较低(低于平均值)。Killip分级为1级的患者在接受胺碘酮治疗后心率显著降低,从平均105±10次/分钟降至88±11次/分钟(p<0.01)。Killip分级为2级的患者心率也有所降低(从118±14次/分钟降至81±39次/分钟),但这些变化无统计学意义。在3至4级Killip分级的3例患者中,1例心率减慢了10次/分钟,其余2例未观察到变化。使用胺碘酮未出现明显副作用。